搜索临床试验以:177Lu-Dotatate PRRT
总计1307个结果
-
Institut Claudius RegaudAdvanced Accelerator Applications招聘中
-
University of Warmia and MazuryStowarzyszenie Pacjentów i Osób Wspierających Chorych na Guzy Neuroendokrynne未知
-
Istituto Scientifico Romagnolo per lo Studio e...主动,不招人
-
Istituto Scientifico Romagnolo per lo Studio e...Istituto Europeo di Oncologia IEO MILANO主动,不招人
-
Sue O'DorisioAdvanced Accelerator Applications撤销
-
Jakob StenmanNovartis; Advanced Accelerator Applications招聘中
-
Ebrahim S DelpassandExcel Diagnostics and Nuclear Oncology Center完全的
-
Memorial Sloan Kettering Cancer Center招聘中
-
Sociedad Española de Medicina Nuclear e Imagen...招聘中消化系统疾病 | 肿瘤 | 组织学类型的肿瘤 | 按部位分类的肿瘤 | 内分泌系统疾病 | 胃肿瘤 | 消化道肿瘤 | 消化系统肿瘤 | 肿瘤、生殖细胞和胚胎 | 内分泌腺肿瘤 | 神经外胚层肿瘤 | 肿瘤,神经组织 | 肠道疾病 | 肠道肿瘤 | 胰腺肿瘤 | 神经内分泌肿瘤 | 肠胃疾病 | 胰腺疾病西班牙
-
Advanced Accelerator Applications主动,不招人
-
Nicholas Fidelman, MDMerck Sharp & Dohme LLC; BTG International Inc.主动,不招人
-
Daiichi Sankyo Co., Ltd.完全的
-
Fundación de investigación HMSyntax for Science, S.L招聘中
-
Peking University尚未招聘
-
Lund University Hospital完全的
-
Advanced Accelerator Applications批准上市
-
Washington University School of Medicine招聘中
-
OHSU Knight Cancer InstituteNovartis; Oregon Health and Science University尚未招聘
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)撤销转移性肾上腺嗜铬细胞瘤 | III 期甲状腺髓样癌 AJCC v8 | IV 期甲状腺髓样癌 AJCC v8 | 局部晚期肾上腺嗜铬细胞瘤 | 局部晚期副神经节瘤 | 转移性副神经节瘤 | 转移性甲状旁腺癌 | 垂体癌 | 生长抑素受体阳性 | IVA 期甲状腺髓样癌 AJCC v8 | IVB 期甲状腺髓样癌 AJCC v8 | IVC 期甲状腺髓样癌 AJCC v8 | 不可切除的肾上腺嗜铬细胞瘤 | 不可切除的副神经节瘤美国
-
Ipsen终止胃癌 | 大肠癌 | 骨癌 | 头颈部鳞状细胞癌 | 晚期癌症 | 复发性疾病 | 胰腺导管腺癌 | 转移性肿瘤美国, 法国, 比利时, 瑞士, 荷兰
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLC; Novartis; GI Research Foundation招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Adenoid Cystic Carcinoma Research Foundation; Progenics Pharmaceuticals, Inc.尚未招聘
-
Novartis Pharmaceuticals招聘中
-
Telix International Pty Ltd尚未招聘
-
Vastra Gotaland RegionAdvanced Accelerator Applications主动,不招人
-
National Cancer Institute (NCI)招聘中
-
Jonsson Comprehensive Cancer Center不再可用